Karen (Chau) Pellett has extensive experience in project and portfolio management in the pharmaceutical industry. Karen has worked in various leadership roles at companies such as Genentech, Pfizer Inc, and currently at Alumis. With a background in chemistry, Karen has successfully led teams in driving drug candidates through early development stages, developing disease area strategies, and overseeing diverse therapeutic areas such as oncology and cardiovascular. Additionally, Karen has played key roles in global manufacturing services, governance teams, and supply chain coordination. Karen holds an MBA in Finance from NYU Stern School of Business and a BA in Chemistry from Amherst College.
January 1, 2024 - present
April, 2023
April, 2022